Gtcr Investment Xi Llc Sells 8,000,000 Shares of Sotera Health (NASDAQ:SHC) Stock

Key Points

• Gtcr Investment Xi Llc sold 8,000,000 shares of Sotera Health at an average price of $15.11, totaling $120.88 million, reducing its ownership by 16.26%.
• Sotera Health reported a quarterly earnings of $0.20 per share, exceeding analysts' expectations and showing a 6.4% increase in revenue compared to last year.
• Wall Street analysts have a consensus rating of "Moderate Buy" for Sotera Health, with an average target price of $16.00.

Sotera Health Company (NASDAQ:SHC - Get Free Report) Director Gtcr Investment Xi Llc sold 8,000,000 shares of the firm's stock in a transaction dated Friday, September 5th. The shares were sold at an average price of $15.11, for a total value of $120,880,000.00. Following the sale, the director owned 41,215,301 shares in the company, valued at $622,763,198.11. The trade was a 16.26% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Sotera Health Trading Down 0.6%

Shares of NASDAQ:SHC traded down $0.10 on Tuesday, reaching $15.81. 2,138,026 shares of the company traded hands, compared to its average volume of 2,409,231. The business's 50-day simple moving average is $13.52 and its 200 day simple moving average is $12.37. Sotera Health Company has a 52 week low of $9.53 and a 52 week high of $16.99. The stock has a market capitalization of $4.49 billion, a P/E ratio of 197.65 and a beta of 1.84. The company has a current ratio of 2.47, a quick ratio of 2.23 and a debt-to-equity ratio of 4.49.

Sotera Health (NASDAQ:SHC - Get Free Report) last announced its quarterly earnings data on Friday, August 8th. The company reported $0.20 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.17 by $0.03. Sotera Health had a return on equity of 39.42% and a net margin of 2.14%.The firm had revenue of $294.34 million for the quarter, compared to analysts' expectations of $275.81 million. During the same period last year, the firm earned $0.19 earnings per share. The company's revenue for the quarter was up 6.4% compared to the same quarter last year. Sotera Health has set its FY 2025 guidance at 0.750-0.820 EPS. As a group, equities analysts anticipate that Sotera Health Company will post 0.61 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on SHC shares. Barclays reaffirmed an "overweight" rating on shares of Sotera Health in a research note on Friday, August 8th. Wall Street Zen raised Sotera Health from a "buy" rating to a "strong-buy" rating in a research note on Saturday, August 16th. Four research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat.com, Sotera Health currently has a consensus rating of "Moderate Buy" and an average target price of $16.00.

Institutional Trading of Sotera Health

Several large investors have recently modified their holdings of SHC. The Manufacturers Life Insurance Company boosted its position in Sotera Health by 2.9% during the 4th quarter. The Manufacturers Life Insurance Company now owns 131,889 shares of the company's stock valued at $1,804,000 after acquiring an additional 3,667 shares in the last quarter. Northern Trust Corp boosted its position in Sotera Health by 23.6% during the 4th quarter. Northern Trust Corp now owns 1,334,367 shares of the company's stock valued at $18,254,000 after acquiring an additional 254,768 shares in the last quarter. Ananym Capital Management LP bought a new stake in Sotera Health during the 4th quarter valued at approximately $13,680,000. BNP Paribas Financial Markets bought a new stake in Sotera Health during the 4th quarter valued at approximately $208,000. Finally, Nomura Holdings Inc. bought a new stake in Sotera Health during the 4th quarter valued at approximately $278,000. 91.03% of the stock is owned by institutional investors.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.